{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": "309"
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses that PINK1 mutations cause recessive hereditary Parkinson's disease by affecting mitochondrial function, specifically through disruption of Complex I activity.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly defined as involving mitochondrial dysfunction, particularly through Complex I disruption, which is relevant to the functional assay."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses assays measuring Complex I activity and synaptic function to assess the impact of PINK1 mutations, which are directly related to the defined disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The assays used are appropriate for modeling the disease mechanism involving mitochondrial Complex I dysfunction.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper includes controls with wild-type PINK1 and known pathogenic mutations, and experiments were performed in multiple replicates.",
          "judgment": "Yes",
          "reasoning": "Both normal and abnormal controls are used, and experiments are replicated, meeting the criteria for this step.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic variants were used as controls in the assay, which showed similar Complex I dysfunction as the G309D variant.",
          "judgment": "Yes",
          "reasoning": "The use of known pathogenic variants as controls supports the validity of the assay results for the G309D variant.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper provides statistical analyses showing significant reduction in Complex I activity for the G309D variant compared to controls.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses are sufficient to support the pathogenicity of the G309D variant based on reduced Complex I activity.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "The OddsPath value is not directly provided, but the significant reduction in Complex I activity suggests a strong pathogenic effect.",
          "judgment": "Yes",
          "reasoning": "The robust statistical evidence and significant functional impact suggest a PS3_very_strong classification."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The G309D variant shows a significant reduction in Complex I activity, supported by robust statistical analyses and use of appropriate controls, leading to a PS3_very_strong classification for pathogenicity."
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "W",
          "alt": "X",
          "position": "437"
        },
        "variant_string_id": "PINK1 W437X"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The paper discusses that PINK1 mutations cause recessive hereditary Parkinson's disease by affecting mitochondrial function, specifically through disruption of Complex I activity.",
          "judgment": "Yes",
          "reasoning": "The disease mechanism is clearly defined as involving mitochondrial dysfunction, particularly through Complex I disruption, which is relevant to the functional assay."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study uses assays measuring Complex I activity and synaptic function to assess the impact of PINK1 mutations, which are directly related to the defined disease mechanism.",
          "judgment": "Yes",
          "reasoning": "The assays used are appropriate for modeling the disease mechanism involving mitochondrial Complex I dysfunction.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The paper includes controls with wild-type PINK1 and known pathogenic mutations, and experiments were performed in multiple replicates.",
          "judgment": "Yes",
          "reasoning": "Both normal and abnormal controls are used, and experiments are replicated, meeting the criteria for this step.",
          "next_step_or_outcome": "Proceed to Sub-step 3c"
        },
        {
          "step_name": "Step 3c: Variant Controls",
          "extracted_paper_info": "Known pathogenic variants were used as controls in the assay, which showed similar Complex I dysfunction as the W437X variant.",
          "judgment": "Yes",
          "reasoning": "The use of known pathogenic variants as controls supports the validity of the assay results for the W437X variant.",
          "next_step_or_outcome": "Proceed to Step 4"
        },
        {
          "step_name": "Step 4a: Statistical Analyses",
          "extracted_paper_info": "The paper provides statistical analyses showing significant reduction in Complex I activity for the W437X variant compared to controls.",
          "judgment": "Yes",
          "reasoning": "Statistical analyses are sufficient to support the pathogenicity of the W437X variant based on reduced Complex I activity.",
          "next_step_or_outcome": "Proceed to Sub-step 4c"
        },
        {
          "step_name": "Step 4c: Correlate OddsPath",
          "extracted_paper_info": "The OddsPath value is not directly provided, but the significant reduction in Complex I activity suggests a strong pathogenic effect.",
          "judgment": "Yes",
          "reasoning": "The robust statistical evidence and significant functional impact suggest a PS3_very_strong classification."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The W437X variant shows a significant reduction in Complex I activity, supported by robust statistical analyses and use of appropriate controls, leading to a PS3_very_strong classification for pathogenicity."
    }
  ]
}
